What does concentration mean in a compounded semaglutide vial?
Compounded semaglutide is dispensed as a sterile injectable solution. The concentration tells you how much active semaglutide is dissolved per unit volume of liquid. A 5mg/mL solution contains 5 milligrams of semaglutide in every milliliter of liquid.
This matters because subcutaneous injections are measured in volume (milliliters or units on an insulin syringe), not weight. To inject a specific milligram dose, you calculate the corresponding volume at your solution’s concentration:
Volume (mL) = Dose (mg) ÷ Concentration (mg/mL)
At 5mg/mL: a 0.5 mg dose = 0.5 ÷ 5 = 0.1 mL
Different compounding pharmacies may prepare semaglutide at different concentrations — 2.5mg/mL, 5mg/mL, 10mg/mL, or others. The dose in milligrams is what matters clinically; the volume is just arithmetic. Never assume one vial’s concentration matches another’s.
Semaglutide 5mg/mL dosage chart: common doses mapped to volume
The table below shows the injection volumes at 5mg/mL that correspond to the dose levels commonly used in semaglutide escalation protocols. This is presented for educational context — your clinician determines which dose applies to you and at which step of a protocol.
| Weekly dose | Volume at 5mg/mL | Typical protocol stage |
|---|---|---|
| 0.25 mg | 0.05 mL | Starting / weeks 1–4 |
| 0.5 mg | 0.10 mL | Escalation step 1 |
| 1.0 mg | 0.20 mL | Escalation step 2 |
| 1.7 mg | 0.34 mL | Escalation step 3 |
| 2.4 mg | 0.48 mL | Maintenance (max dose in published weight-mgmt protocols) |
Doses shown are for reference based on published clinical protocols. Do not use this table to self-prescribe or adjust your dose. Your clinician and pharmacy documentation take precedence.
A dosage chart only tells you the arithmetic — the milligram dose and the schedule are a clinical decision, not a calculator’s.
Why does semaglutide require dose escalation?
The most common side effects of semaglutide — nausea, vomiting, diarrhea, constipation — are dose-dependent and tend to be most pronounced at initiation and after each dose increase. Starting at a low dose and increasing gradually over weeks allows the GI tract and appetite-regulating centers to adapt, which substantially reduces the rate and severity of these effects.
In the clinical trials that established semaglutide’s efficacy for weight management, the standard protocol started participants at 0.25 mg per week for four weeks, then escalated every four weeks through 0.5 mg, 1 mg, 1.7 mg, and finally 2.4 mg. That 16-week escalation was deliberate — it reflected the balance between building toward the therapeutic dose and managing tolerability.
Clinician-supervised protocols follow similar logic but individualize the pace. Some patients tolerate faster escalation; others need more time at an intermediate dose. Some patients achieve meaningful clinical response at lower doses and may not need to reach 2.4 mg. Dose decisions should be driven by your response and your clinician’s assessment — not by a chart that shows the maximum possible dose.
How do you draw your dose accurately?
Accurate dosing starts with the right syringe. Compounded semaglutide at 5mg/mL is typically drawn with insulin syringes. The two most common formats are:
- U-100 insulin syringe (1 mL): marked in 0.01 mL increments. At 5mg/mL, each 0.01 mL graduation = 0.05 mg of semaglutide. A 0.5 mg dose = fill to the 0.10 mL mark.
- U-100 insulin syringe (0.5 mL): also in 0.01 mL increments, with a shorter barrel that can make small volumes easier to read. Same math applies.
Your pharmacy will specify the correct syringe for your formulation and may include written or visual instructions. Follow those. If you are unsure about the correct volume for your prescribed dose, contact your prescribing clinician or pharmacy before injecting — not an online calculator.
How should you store and handle semaglutide at 5mg/mL?
Compounded semaglutide is a peptide solution that requires refrigeration. Standard storage is between 2°C and 8°C (36°F and 46°F). Do not freeze. Keep away from light. Most compounding pharmacies will indicate an expiry or beyond-use date on the vial label — this date applies specifically to the compounded preparation, not the branded product timeline.
Before drawing a dose, allow the vial to reach room temperature for a few minutes if it has been refrigerated — this makes the injection more comfortable. Do not shake the vial; if there is any particulate matter or discoloration, do not use the medication and contact your pharmacy.
Frequently asked questions
What does semaglutide 5mg/mL mean?
The notation 5mg/mL describes the concentration of the semaglutide solution — 5 milligrams of active semaglutide per milliliter of liquid. To determine how many milligrams you are injecting, multiply the volume you draw (in mL) by 5. For example, 0.1 mL delivers 0.5 mg of semaglutide.
How do I read a semaglutide dosage chart?
A semaglutide dosage chart at 5mg/mL maps a weekly milligram dose (e.g., 0.25 mg, 0.5 mg, 1 mg, 1.7 mg, 2.4 mg) to the injection volume in milliliters. At 5mg/mL: 0.25 mg = 0.05 mL; 0.5 mg = 0.1 mL; 1 mg = 0.2 mL; 1.7 mg = 0.34 mL; 2.4 mg = 0.48 mL. Your clinician confirms the correct dose and volume for your prescription.
What is the typical starting dose for compounded semaglutide?
Standard dose-escalation protocols for semaglutide typically begin at 0.25 mg per week for the first four weeks, then increase based on tolerability and clinical response. Your clinician determines your specific starting dose and escalation schedule based on your health history and goals.
Can I adjust my own semaglutide dose based on a chart?
No. Dose adjustments for compounded semaglutide should be made by your prescribing clinician, not by self-titrating against an online chart. The appropriate dose depends on your individual response, side effects, and clinical goals. Using the wrong volume can result in under- or over-dosing.
Does concentration affect how semaglutide works?
The concentration (mg/mL) determines how much volume you inject to deliver a given dose. The pharmacological effect is determined by how much semaglutide reaches the GLP-1 receptor — which depends on the milligram dose delivered, not the concentration per se. Two formulations at different concentrations that deliver the same milligram dose have the same active effect.
What syringes are used for subcutaneous semaglutide injection?
Compounded semaglutide is typically drawn using insulin syringes (U-100 or U-40) with short, fine-gauge needles (typically 29–31 gauge, 4–8 mm). Your pharmacy will specify the appropriate syringe type for your concentration. Never share syringes.